Insights

At Molecule to Market, we’re always spotlighting the game changers in pharma and biotech. That’s exactly why we’re proud to be a partner and sponsor of Festival of Biologics USA 2025, hosted by Terrapinn. This event isn’t just another date on the industry calendar. It’s where biologics leaders, innovators, and disruptors come together to shape …

A lookback at 2024 and how the pharma services space was shaped by market headwinds, GLP-1, rising stars and green shoots.

From strategy to success: Crafting your commercial growth blueprint CPHI Milan – Wednesday, October 9th – Fiera Milano LEM 1, Room A – 4:30pm onward Tired of the same old, same old at CPHI? Ready for actionable insights tailored to life science marketers to supercharge your growth strategy? Join us at CPHI Worldwide in Milan …

Tune into our top podcast episodes of 2024 so far covering AI, GLP-1, raising capital, career advice & much more.

Raman, takes the hot seat on the CPHI podcast, and is interviewed on the power of digital marketing in life sciences by Lucy Chard.

According to recent studies, 54% of life sciences companies are already using AI, and 75% are planning to use machine learning shortly.  Are you ready to take a leap of faith into a new world that can help the drug development process accelerate?  How AI is transforming data analysis Artificial intelligence is revolutionizing the life …

Tune into our top podcast episodes of 2023 covering AI, Biotech trends, rare disease medicines, navigating regulatory challenges & much more.

Molecule to Market podcast with Culture’s CEO, Will Patrick

Welcome to the Molecule to Market round-up for January and February. Here you’ll find a summary of the episodes we’ve released so far this year. No doubt you’ve already listened to them all twice already, but on the off chance you’ve missed one – here are all the choicest cuts. January 6: 100 episodes of …

Catch up on 100 episodes of Molecule to Market, where Raman discusses the podcast’s journey and what’s to come in 2023 with editr Dan Stanton.